From Cancer Gene Therapy to Influenza Vaccines
Adenoviruses have been used as delivery vectors in gene therapy applications for several decades, largely for cancer therapy applications, but they are rapidly gaining interest in the vaccinology community due their potency as vaccines for infectious disease. This talk will provide an overview of the background of Ad vectors, their limitations and promise for the future.
Date:
27 October 2015, 13:00 (Tuesday, 3rd week, Michaelmas 2015)
Venue:
Sir William Dunn School of Pathology, South Parks Road OX1 3RE
Venue Details:
EPA seminar room
Speaker:
Lynda Coughlan (University of Oxford)
Organising department:
Sir William Dunn School of Pathology
Organisers:
Rebecca Moore (University of Oxford),
Helen Farr (University of Oxford),
Joanna Miller (University of Oxford),
Eva Gluenz (University of Oxford),
Kenny Moore (University of Oxford),
Rachel Exley (University of Oxford)
Part of:
Bug Sessions in infectious disease
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Rebecca Moore
